Skip to main content

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

AbCellera Biologics Inc. - Business Wire - Wed Feb 11, 3:05PM CST

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

  • TD Cowen 46th Annual Health Care Conference, March 4, 2026
  • KeyBanc Capital Markets Healthcare Forum, March 17, 2026
  • Bloom Burton & Co. Healthcare Investor Conference, April 21-22, 2026

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc .

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com .

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).